These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19625274)

  • 1. Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.
    Saratzis A; Kitas GD; Saratzis N; Melas N
    Angiology; 2010 Feb; 61(2):137-44. PubMed ID: 19625274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
    Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
    Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.
    Sukhija R; Aronow WS; Sandhu R; Kakar P; Babu S
    Am J Cardiol; 2006 Jan; 97(2):279-80. PubMed ID: 16442379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
    Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
    Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin suppresses experimental aortic aneurysm expansion.
    Kalyanasundaram A; Elmore JR; Manazer JR; Golden A; Franklin DP; Galt SW; Zakhary EM; Carey DJ
    J Vasc Surg; 2006 Jan; 43(1):117-24. PubMed ID: 16414398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a role for statins in immunomodulation.
    Mach F
    Mol Interv; 2002 Dec; 2(8):478-80. PubMed ID: 14993398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins enhance circulating vitamin E.
    Cangemi R; Loffredo L; Carnevale R; Pignatelli P; Violi F
    Int J Cardiol; 2008 Jan; 123(2):172-4. PubMed ID: 17306387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
    Neuhaus O; Hartung HP
    Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.
    Shiraya S; Miyake T; Aoki M; Yoshikazu F; Ohgi S; Nishimura M; Ogihara T; Morishita R
    Atherosclerosis; 2009 Jan; 202(1):34-40. PubMed ID: 18482727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms.
    Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Chalifour LE
    Can J Physiol Pharmacol; 2009 Nov; 87(11):915-22. PubMed ID: 19935899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
    Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
    Waehre T; Yndestad A; Smith C; Haug T; Tunheim SH; Gullestad L; Frøland SS; Semb AG; Aukrust P; Damås JK
    Circulation; 2004 Apr; 109(16):1966-72. PubMed ID: 15051633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
    Wilson WR; Evans J; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of abdominal aortic aneurysm.
    Golledge J; Powell JT
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):267-73. PubMed ID: 17540588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.
    Mastoraki ST; Toumpoulis IK; Anagnostopoulos CE; Tiniakos D; Papalois A; Chamogeorgakis TP; Angouras DC; Rokkas CK
    Ann Vasc Surg; 2012 Feb; 26(2):250-8. PubMed ID: 22222170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.
    VAN KUIJK JP; FLU WJ; WITTEVEEN OP; VOUTE M; BAX JJ; POLDERMANS D
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):599-609. PubMed ID: 19741575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts.
    Diehm N; Dick F; Schaffner T; Schmidli J; Kalka C; Di Santo S; Voelzmann J; Baumgartner I
    Prog Cardiovasc Dis; 2007; 50(3):209-17. PubMed ID: 17976505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.